Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC

Jose Carlos Benitez; Laura Mezquita; Rapahël Colle; Lambros Tselikas; Angela Botticella; Caroline Caramella; Benjamin Besse

doi:10.1016/j.jtho.2019.07.001

Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC

Jose Carlos Benitez, Laura Mezquita, Rapahël Colle, Lambros Tselikas, Angela Botticella, Caroline Caramella, Benjamin Besse

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

4 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	e215-e216
journal	Journal of Thoracic Oncology
Volume	14
Numéro de publication	10
Les DOIs	https://doi.org/10.1016/j.jtho.2019.07.001
état	Publié - 1 oct. 2019

Accès au document

10.1016/j.jtho.2019.07.001

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{4d0896477f79458499f5038cae4c5375,

title = "Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC",

author = "Benitez, {Jose Carlos} and Laura Mezquita and Rapah{\"e}l Colle and Lambros Tselikas and Angela Botticella and Caroline Caramella and Benjamin Besse",

note = "Funding Information: Disclosure: Dr. Besse has received grants from Abbvie, Amgen, AstraZeneca, Biogen, Blueprint Medicines, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Ignyta, IPSEN, Merck KGaA, MSD, Nektar, Onxeo, Pfizer, PharmaMar, Sanofi, Spectrum Pharmaceuticals, Takeda, and Tiziana Pharma. The remaining authors declare no conflict of interest.",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/j.jtho.2019.07.001",

language = "English",

volume = "14",

pages = "e215--e216",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

number = "10",

}

TY - JOUR

T1 - Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC

AU - Benitez, Jose Carlos

AU - Mezquita, Laura

AU - Colle, Rapahël

AU - Tselikas, Lambros

AU - Botticella, Angela

AU - Caramella, Caroline

AU - Besse, Benjamin

N1 - Funding Information: Disclosure: Dr. Besse has received grants from Abbvie, Amgen, AstraZeneca, Biogen, Blueprint Medicines, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Ignyta, IPSEN, Merck KGaA, MSD, Nektar, Onxeo, Pfizer, PharmaMar, Sanofi, Spectrum Pharmaceuticals, Takeda, and Tiziana Pharma. The remaining authors declare no conflict of interest.

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85071439555&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2019.07.001

DO - 10.1016/j.jtho.2019.07.001

M3 - Article

C2 - 31302233

AN - SCOPUS:85071439555

SN - 1556-0864

VL - 14

SP - e215-e216

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -